ADAMTS13 | ADAM metallopeptidase with thrombospondin type 1 motif, 13 | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
ADAMTS5 | ADAM metallopeptidase with thrombospondin type 1 motif, 5 | Cancer-related genes Enzymes Predicted secreted proteins
| | | | | Tissue enhanced |
ADAMTS6 | ADAM metallopeptidase with thrombospondin type 1 motif, 6 | Cancer-related genes Enzymes Predicted secreted proteins
| | | | | Mixed |
ADAR | Adenosine deaminase, RNA-specific | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins
| | | | | Expressed in all |
ADARB1 | Adenosine deaminase, RNA-specific, B1 | Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
ADAT1 | Adenosine deaminase, tRNA-specific 1 | Enzymes Predicted intracellular proteins
| | | | | Expressed in all |
ADCK3 | AarF domain containing kinase 3 | Disease related genes Enzymes Mitochondrial proteins Potential drug targets Predicted intracellular proteins
| | | | | Tissue enriched |
ADCK4 | AarF domain containing kinase 4 | Disease related genes Enzymes Potential drug targets Predicted intracellular proteins
| | | | | Expressed in all |
ADCK5 | AarF domain containing kinase 5 | Enzymes Predicted membrane proteins
| | | | | Mixed |
ADCY2 | Adenylate cyclase 2 (brain) | Enzymes Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
ADCY8 | Adenylate cyclase 8 (brain) | Enzymes Predicted intracellular proteins Predicted membrane proteins
| | | | | Group enriched |
ADGB | Androglobin | Enzymes Predicted intracellular proteins
| | | | | Group enriched |
ADH1A | Alcohol dehydrogenase 1A (class I), alpha polypeptide | Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins
| | | | | Tissue enriched |
ADH1B | Alcohol dehydrogenase 1B (class I), beta polypeptide | Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins
| | | | | Group enriched |
ADH1C | Alcohol dehydrogenase 1C (class I), gamma polypeptide | Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins
| | | | | Group enriched |
ADH4 | Alcohol dehydrogenase 4 (class II), pi polypeptide | Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Tissue enriched |
ADH7 | Alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide | Enzymes Predicted intracellular proteins
| | | | | Tissue enriched |
ADI1 | Acireductone dioxygenase 1 | Enzymes Predicted intracellular proteins Predicted secreted proteins
| | | | | Expressed in all |
ADK | Adenosine kinase | Disease related genes Enzymes FDA approved drug targets Predicted intracellular proteins
| | | | | Expressed in all |
ADO | 2-aminoethanethiol (cysteamine) dioxygenase | Enzymes Predicted intracellular proteins
| | | | | Expressed in all |
ADPRHL2 | ADP-ribosylhydrolase like 2 | Enzymes Predicted secreted proteins
| | | | | Expressed in all |
ADPRM | ADP-ribose/CDP-alcohol diphosphatase, manganese-dependent | Enzymes Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
ADRBK1 | Adrenergic, beta, receptor kinase 1 | Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
ADSL | Adenylosuccinate lyase | Disease related genes Enzymes Potential drug targets Predicted intracellular proteins
| | | | | Expressed in all |
ADSS | Adenylosuccinate synthase | Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
AEBP1 | AE binding protein 1 | Enzymes Predicted intracellular proteins Predicted secreted proteins
| | | | | Expressed in all |
AFG3L2 | AFG3-like AAA ATPase 2 | Disease related genes Enzymes Mitochondrial proteins Plasma proteins Potential drug targets Predicted membrane proteins
| | | | | Expressed in all |
AGA | Aspartylglucosaminidase | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins Predicted secreted proteins
| | | | | Expressed in all |
AGK | Acylglycerol kinase | Disease related genes Enzymes Mitochondrial proteins Potential drug targets Predicted intracellular proteins Predicted secreted proteins
| | | | | Expressed in all |
AGL | Amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins
| | | | | Expressed in all |
AGMAT | Agmatine ureohydrolase (agmatinase) | Enzymes Mitochondrial proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
AGO2 | Argonaute RISC catalytic component 2 | Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
AGPAT9 | 1-acylglycerol-3-phosphate O-acyltransferase 9 | Enzymes Predicted membrane proteins
| | | | | Tissue enhanced |
AGPS | Alkylglycerone phosphate synthase | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted secreted proteins
| | | | | Expressed in all |
AGTPBP1 | ATP/GTP binding protein 1 | Enzymes Predicted intracellular proteins Predicted secreted proteins
| | | | | Expressed in all |
AGXT | Alanine-glyoxylate aminotransferase | Disease related genes Enzymes Mitochondrial proteins Plasma proteins Potential drug targets Predicted intracellular proteins
| | | | | Tissue enriched |
AHCY | Adenosylhomocysteinase | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins
| | | | | Expressed in all |
AHCYL1 | Adenosylhomocysteinase-like 1 | Enzymes Predicted intracellular proteins
| | | | | Expressed in all |
AK1 | Adenylate kinase 1 | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins
| | | | | Group enriched |
AK4 | Adenylate kinase 4 | Enzymes Mitochondrial proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
AK5 | Adenylate kinase 5 | Enzymes Predicted intracellular proteins
| | | | | Tissue enriched |
AK9 | Adenylate kinase 9 | Cancer-related genes Enzymes Predicted intracellular proteins
| | | | | Expressed in all |
AKR1B1 | Aldo-keto reductase family 1, member B1 (aldose reductase) | Cancer-related genes Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Tissue enriched |
AKR1C2 | Aldo-keto reductase family 1, member C2 | Disease related genes Enzymes FDA approved drug targets Predicted intracellular proteins
| | | | | Expressed in all |
AKR1C3 | Aldo-keto reductase family 1, member C3 | Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
AKR1D1 | Aldo-keto reductase family 1, member D1 | Disease related genes Enzymes FDA approved drug targets Predicted intracellular proteins
| | | | | Tissue enriched |
AKR1E2 | Aldo-keto reductase family 1, member E2 | Enzymes Predicted intracellular proteins
| | | | | Tissue enriched |
AKR7A2 | Aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase) | Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
AKT1 | V-akt murine thymoma viral oncogene homolog 1 | Cancer-related genes Disease related genes Enzymes Potential drug targets Predicted intracellular proteins RAS pathway related proteins
| | | | | Expressed in all |
AKT3 | V-akt murine thymoma viral oncogene homolog 3 | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins RAS pathway related proteins
| | | | | Expressed in all |